Ronald N. Marcus, MD | Psychiatrist.com

Original Research

The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

June 15, 2007

Robert M. Berman , Ronald N. Marcus , René Swanink , et al

Original Research

Aripiprazole Effects in Patients With Acute Schizophrenia Experiencing Higher or Lower Agitation: A Post Hoc Analysis of 4 Randomized, Placebo-Controlled Clinical Trials

May 15, 2007

Stephen R. Marder , Britt West , Gina S. Lau , et al

Original Research

Aripiprazole for Treatment-Resistant Schizophrenia: Results of a Multicenter, Randomized, Double-Blind, Comparison Study Versus Perphenazine

February 15, 2007

John M. Kane , Herbert Y. Meltzer , William H. Carson, Jr. , et al

Original Research

Efficacy and Safety of Intramuscular Aripiprazole in Patients With Acute Agitation: A Randomized, Double-Blind, Placebo-Controlled Trial

January 15, 2007

Tram K. Tran-Johnson , David A. Sack , Ronald N. Marcus , et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled 26-Week Trial of Aripiprazole in Recently Manic Patients With Bipolar I Disorder.

April 15, 2006

Paul E. Keck, Jr. , Joseph R. Calabrese , Robert D. McQuade , et al

« 1 2